| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 10.19% | Stephens & Co. | → $775 | Reiterates | Equal-Weight → Equal-Weight |
| 07/28/2023 | -7.16% | Morgan Stanley | $647 → $653 | Maintains | Underweight |
| 07/28/2023 | 12.32% | Baird | $795 → $790 | Maintains | Outperform |
| 07/12/2023 | -8.01% | Morgan Stanley | $600 → $647 | Maintains | Underweight |
| 07/12/2023 | 16.58% | UBS | $815 → $820 | Downgrades | Buy → Neutral |
| 05/01/2023 | 13.74% | Loop Capital | $750 → $800 | Maintains | Buy |
| 05/01/2023 | -0.48% | Stephens & Co. | $655 → $700 | Maintains | Equal-Weight |
| 05/01/2023 | -14.69% | Morgan Stanley | $555 → $600 | Maintains | Underweight |
| 04/28/2023 | 13.74% | Oppenheimer | $785 → $800 | Maintains | Outperform |
| 04/28/2023 | 8.05% | Baird | $730 → $760 | Maintains | Outperform |
| 04/19/2023 | -21.09% | Morgan Stanley | $537 → $555 | Maintains | Underweight |
| 02/24/2023 | -3.46% | RBC Capital | $502 → $679 | Upgrades | Underperform → Sector Perform |
| 02/13/2023 | 6.63% | Loop Capital | $670 → $750 | Maintains | Buy |
| 02/03/2023 | -23.65% | Morgan Stanley | $490 → $537 | Maintains | Underweight |
| 02/03/2023 | -28.63% | RBC Capital | $439 → $502 | Maintains | Underperform |
| 02/03/2023 | 11.61% | Oppenheimer | $660 → $785 | Maintains | Outperform |
| 01/24/2023 | -7.59% | Baird | $640 → $650 | Maintains | Outperform |
| 01/06/2023 | -30.33% | Morgan Stanley | $485 → $490 | Maintains | Underweight |
| 11/29/2022 | -1.19% | UBS | $635 → $695 | Maintains | Buy |
| 11/15/2022 | -10.43% | Atlantic Equities | → $630 | Downgrades | Overweight → Neutral |
| 11/14/2022 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 10/31/2022 | -31.04% | Morgan Stanley | $448 → $485 | Maintains | Underweight |
| 10/31/2022 | -9.01% | Baird | $590 → $640 | Maintains | Outperform |
| 08/01/2022 | -14.69% | Baird | $505 → $600 | Maintains | Outperform |
| 08/01/2022 | -36.3% | Morgan Stanley | $421 → $448 | Maintains | Underweight |
| 08/01/2022 | -40% | RBC Capital | $399 → $422 | Maintains | Underperform |
| 08/01/2022 | -14.69% | Stephens & Co. | $565 → $600 | Maintains | Equal-Weight |
| 07/15/2022 | -40.14% | Morgan Stanley | $449 → $421 | Maintains | Underweight |
| 05/31/2022 | -36.16% | Morgan Stanley | $474 → $449 | Maintains | Underweight |
| 04/29/2022 | -32.61% | Morgan Stanley | $480 → $474 | Maintains | Underweight |
| 04/29/2022 | -36.02% | RBC Capital | $424 → $450 | Maintains | Underperform |
| 04/29/2022 | -32.47% | Wells Fargo | $450 → $475 | Maintains | Underweight |
| 04/14/2022 | -31.76% | Morgan Stanley | $562 → $480 | Downgrades | Equal-Weight → Underweight |
| 04/06/2022 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
| 03/15/2022 | -17.54% | Atlantic Equities | → $580 | Upgrades | Neutral → Overweight |
| 02/04/2022 | -20.1% | Morgan Stanley | $536 → $562 | Maintains | Equal-Weight |
| 02/04/2022 | -17.54% | Oppenheimer | $535 → $580 | Maintains | Outperform |
| 01/14/2022 | -23.79% | Morgan Stanley | $510 → $536 | Maintains | Equal-Weight |
| 11/01/2021 | -23.94% | Oppenheimer | $500 → $535 | Maintains | Outperform |
| 11/01/2021 | -27.49% | Morgan Stanley | $492 → $510 | Maintains | Equal-Weight |
| 11/01/2021 | -44.41% | RBC Capital | $378 → $391 | Maintains | Underperform |
| 08/03/2021 | -25.36% | Loop Capital | → $525 | Initiates Coverage On | → Buy |
| 08/02/2021 | -30.05% | Morgan Stanley | $462 → $492 | Maintains | Equal-Weight |
| 08/02/2021 | -46.26% | RBC Capital | $369 → $378 | Maintains | Underperform |
| 08/02/2021 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 05/04/2021 | -38.15% | Atlantic Equities | → $435 | Upgrades | Underweight → Neutral |
| 05/03/2021 | -28.91% | Baird | $452 → $500 | Maintains | Outperform |
| 05/03/2021 | -47.54% | RBC Capital | $354 → $369 | Maintains | Underperform |
| 05/03/2021 | -34.88% | Deutsche Bank | $409 → $458 | Maintains | Hold |
| 05/03/2021 | -28.91% | Oppenheimer | $420 → $500 | Maintains | Outperform |
| 05/03/2021 | -34.31% | Morgan Stanley | $427 → $462 | Maintains | Equal-Weight |
| 05/03/2021 | -26.07% | Jefferies | $460 → $520 | Maintains | Buy |
| 05/03/2021 | -34.6% | Raymond James | $400 → $460 | Maintains | Outperform |
| 04/12/2021 | -39.29% | Morgan Stanley | $433 → $427 | Maintains | Equal-Weight |
| 03/10/2021 | -38.44% | Morgan Stanley | $405 → $433 | Maintains | Equal-Weight |
| 03/04/2021 | -40.29% | Oppenheimer | $400 → $420 | Maintains | Outperform |
| 02/04/2021 | -42.42% | Morgan Stanley | $401 → $405 | Maintains | Equal-Weight |
| 02/01/2021 | -42.42% | Deutsche Bank | $391 → $405 | Maintains | Hold |
| 10/23/2020 | -42.99% | Morgan Stanley | $366 → $401 | Maintains | Equal-Weight |
| 10/23/2020 | -43.13% | Raymond James | $390 → $400 | Maintains | Outperform |
| 10/13/2020 | -36.02% | Jefferies | $410 → $450 | Maintains | Buy |
| 09/16/2020 | -40.85% | UBS | → $416 | Initiates Coverage On | → Buy |
| 09/08/2020 | — | Raymond James | Upgrades | Market Perform → Outperform | |
| 07/24/2020 | -44.55% | Jefferies | $298 → $390 | Maintains | Buy |
| 07/24/2020 | -47.96% | Morgan Stanley | $324 → $366 | Maintains | Equal-Weight |
| 07/21/2020 | -48.82% | Baird | $335 → $360 | Maintains | Outperform |
| 07/09/2020 | -58.06% | Gordon Haskett | → $295 | Upgrades | Underperform → Hold |
| 06/30/2020 | -53.93% | Morgan Stanley | $298 → $324 | Maintains | Equal-Weight |
| 06/23/2020 | -58.63% | JP Morgan | $270 → $291 | Maintains | Neutral |
| 06/02/2020 | -45.97% | Longbow Research | → $380 | Upgrades | Neutral → Buy |
| 04/24/2020 | -53.79% | Oppenheimer | $335 → $325 | Maintains | Outperform |
| 04/24/2020 | -72.84% | RBC Capital | $194 → $191 | Maintains | Underperform |
| 04/24/2020 | -64.46% | Wells Fargo | $275 → $250 | Maintains | Equal-Weight |
| 04/15/2020 | -59.91% | Morgan Stanley | $259 → $282 | Maintains | Equal-Weight |
| 04/13/2020 | -57.35% | Stephens & Co. | $322 → $300 | Reiterates | → Equal-Weight |
| 03/27/2020 | -57.35% | Baird | $340 → $300 | Upgrades | Neutral → Outperform |
| 03/23/2020 | -63.18% | Morgan Stanley | $291 → $259 | Maintains | Equal-Weight |
| 03/17/2020 | -58.63% | Morgan Stanley | $342 → $291 | Maintains | Equal-Weight |
| 02/12/2020 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 02/07/2020 | -53.65% | Buckingham Research | $342 → $326 | Maintains | Neutral |
| 02/03/2020 | — | Gabelli & Co. | Upgrades | Hold → Buy | |
| 01/31/2020 | -54.22% | Stephens & Co. | $330 → $322 | Maintains | Equal-Weight |
| 01/31/2020 | -51.38% | Morgan Stanley | $338 → $342 | Maintains | Equal-Weight |
| 01/31/2020 | -58.77% | Wells Fargo | $330 → $290 | Maintains | Equal-Weight |
| 01/24/2020 | -51.38% | Buckingham Research | $329 → $342 | Maintains | Neutral |
| 12/11/2019 | -51.94% | Morgan Stanley | $281 → $338 | Upgrades | Underweight → Equal-Weight |
| 10/24/2019 | -60.05% | Morgan Stanley | $276 → $281 | Maintains | Underweight |
| 10/24/2019 | -51.66% | Baird | $320 → $340 | Maintains | Neutral |
| 10/24/2019 | -53.22% | Buckingham Research | $325 → $329 | Maintains | Neutral |
| 10/10/2019 | -57.2% | JP Morgan | $297 → $301 | Maintains | Neutral |
| 10/08/2019 | -53.79% | Buckingham Research | $295 → $325 | Maintains | Neutral |
| 07/29/2019 | -60.76% | Morgan Stanley | $258 → $276 | Maintains | Underweight |
| 07/26/2019 | -56.64% | Stephens & Co. | $292 → $305 | Maintains | Equal-Weight |
| 07/26/2019 | -58.06% | Buckingham Research | $291 → $295 | Maintains | Neutral |
| 07/17/2019 | -58.63% | Buckingham Research | $312 → $291 | Maintains | Neutral |
| 06/14/2019 | -63.32% | Morgan Stanley | $273 → $258 | Maintains | Underweight |
| 05/17/2019 | — | Gordon Haskett | Upgrades | Reduce → Hold | |
| 04/24/2019 | -61.19% | Morgan Stanley | $266 → $273 | Maintains | Underweight |
| 04/23/2019 | -55.93% | BMO Capital | $320 → $310 | Maintains | Market Perform |
| 04/17/2019 | -55.07% | Buckingham Research | $309 → $316 | Maintains | Neutral |
| 04/12/2019 | — | Gordon Haskett | Downgrades | Hold → Underperform | |
| 01/15/2019 | — | Macquarie | Upgrades | Neutral → Outperform | |
| 12/11/2018 | -53.79% | Buckingham Research | → $325 | Initiates Coverage On | → Neutral |
| 10/17/2018 | -53.08% | BMO Capital | $332 → $330 | Maintains | Market Perform |
| 08/30/2018 | -48.11% | UBS | $340 → $365 | Maintains | Neutral |
| 08/22/2018 | -49.1% | Macquarie | $314 → $358 | Maintains | Neutral |
What is the target price for W.W. Grainger (GWW)?
The latest price target for W.W. Grainger (NYSE: GWW) was reported by Stephens & Co. on August 18, 2023. The analyst firm set a price target for $775.00 expecting GWW to rise to within 12 months (a possible 10.19% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for W.W. Grainger (GWW)?
The latest analyst rating for W.W. Grainger (NYSE: GWW) was provided by Stephens & Co., and W.W. Grainger reiterated their equal-weight rating.
When is the next analyst rating going to be posted or updated for W.W. Grainger (GWW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of W.W. Grainger, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for W.W. Grainger was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
Is the Analyst Rating W.W. Grainger (GWW) correct?
While ratings are subjective and will change, the latest W.W. Grainger (GWW) rating was a reiterated with a price target of $0.00 to $775.00. The current price W.W. Grainger (GWW) is trading at is $703.35, which is within the analyst's predicted range.